CollPlant Biotechnologies Ltd.
  • About
    • About Us
    • Management Team
    • Board of Directors
    • Advisory Board
    • Partnering
  • Technology
    • rhCollagen
    • 3D Bioprinting
  • Product Pipeline
    • Collink.3D Bioinks
    • Gut-on-a-Chip
    • Medical Aesthetics
      • Dermal Fillers
      • Breast Implants
    • Vergenix products
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Media Room
    • Publications
    • Posters and Presentations
    • Media Coverage
    • Videos
  • Contact
    • Contact us
    • Careers
search

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • Events
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News & Events

  • Overview
  • Press Releases
  • Events
  • Email Alerts
Feb 18, 2021 9:31am EST

CollPlant Issues Letter to Shareholders

Feb 18, 2021 7:00am EST

CollPlant Announces Closing of $35.0 Million Registered Direct Offering of American Depositary Shares

Feb 11, 2021 11:22pm EST

CollPlant Announces $35.0 Million Registered Direct Offering of American Depositary Shares

Feb 08, 2021 7:00am EST

CollPlant Announces Development and Global Commercialization Agreement with Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft Tissue Filler Products

Dec 10, 2020 7:00am EST

CollPlant to Supply rhCollagen to STEMCELL Technologies for Use in a Broad Range of Cell Culture Applications

Dec 01, 2020 7:00am EST

CollPlant Biotechnologies Reports Third Quarter (Q3) 2020 Financial Results and Provides Business Update

Nov 10, 2020 7:00am EST

CollPlant Announces Early Development Program of Antiviral Agent for Potential Treatment of COVID-19 Patients

Oct 26, 2020 7:00am EDT

CollPlant Receives Substantial First Order for its Vergenix™ Flowable Gel Product in Ukraine

Sep 21, 2020 7:00am EDT

CollPlant and United Therapeutics Announce Exercise of Option that will Expand their Collaboration to Include 3D Bioprinting of Human Kidneys for Transplant

Sep 16, 2020 12:00pm EDT

CollPlant Biotechnologies Presents on the Use of Novel, Plant-Derived, Recombinant Human Collagen for Anti-Aging Therapies at the Science of Aging Virtual Symposium 2020

RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...14
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

    Details

    exploreCollPlant Ltd

    4 Oppenheimer Street
    P.O. Box 4132
    Rehovot 7670104, Israel

    LinkedinLinkedIn YoutubeYoutube TwitterTwitter
    local_phone+972 73 2325600
    local_printshop+972 73 2325602
    mailinfo@collplant.com

     
     

    ® 2023 CollPlant Biotechnologies Ltd. All rights reserved. Version: CPW 02-20